Shuttle Pharmaceuticals Holdings, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
SHPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
401 Professional Drive, Suite 260, Gaithersburg, MD

There are no Buy or Sell transactions made by insiders since 12/23/2023

Shuttle Pharmaceuticals Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mira Jung Chief Scientific Officer $1.53M May 1, 2024
Anatoly Dritschilo CEO and Chairman, Director, 10%+ Owner $1.48M Aug 14, 2023
Milton Brown Director $507K Dec 13, 2023
Timothy J. Lorber Chief Financial Officer $105K Jun 13, 2024
William Adkins Former Director $85.3K Dec 29, 2022
Bette Jacobs Director $62.6K Dec 13, 2023
Michael Vander Chief Financial Officer $48.1K Mar 8, 2024
Peter Dritschilo President and COO $3.04K Dec 29, 2022
Chris Senanayake Director $1.29K Dec 29, 2022
Joshua Schafer Director $1.25K Aug 29, 2022
Tyvin Rich Chief Medical Officer $1.13K Dec 29, 2022
Steven Richards Director $791 Dec 29, 2022

Recent Insider Transactions by Companies or Individuals for Shuttle Pharmaceuticals Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.